These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25100072)

  • 21. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa.
    Heruc GA; Little TJ; Kohn MR; Madden S; Clarke SD; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E565-E573. PubMed ID: 29969316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid gastric emptying in diabetes mellitus: Pathophysiology and clinical importance.
    Goyal RK; Cristofaro V; Sullivan MP
    J Diabetes Complications; 2019 Nov; 33(11):107414. PubMed ID: 31439470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans.
    Woerle HJ; Albrecht M; Linke R; Zschau S; Neumann C; Nicolaus M; Gerich J; Göke B; Schirra J
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E103-9. PubMed ID: 17971511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
    Perano SJ; Couper JJ; Horowitz M; Martin AJ; Kritas S; Sullivan T; Rayner CK
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2486-93. PubMed ID: 24670086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men.
    Bitarafan V; Fitzgerald PCE; Little TJ; Meyerhof W; Jones KL; Wu T; Horowitz M; Feinle-Bisset C
    Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R263-R273. PubMed ID: 31774306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes.
    Yu K; Ke MY; Li WH; Zhang SQ; Fang XC
    Asia Pac J Clin Nutr; 2014; 23(2):210-8. PubMed ID: 24901089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of gastric emptying as a therapeutic approach to glycaemic control.
    Moyses C; Young A; Kolterman O
    Diabet Med; 1996 Sep; 13(9 Suppl 5):S34-8. PubMed ID: 8894469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of postprandial glucose control.
    Bell DS
    South Med J; 2001 Aug; 94(8):804-9. PubMed ID: 11549192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
    Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric Emptying Is More Rapid in Adolescents With Type 1 Diabetes and Impacts on Postprandial Glycemia.
    Perano SJ; Rayner CK; Kritas S; Horowitz M; Donaghue K; Mpundu-Kaambwa C; Giles L; Couper JJ
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2248-53. PubMed ID: 25871840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of amylin in glucose homeostasis and its perspective use in diabetes management].
    Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T
    Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum high-molecular weight adiponectin is related to early postprandial glycemic increases and gastric emptying in patients with type 2 diabetes mellitus.
    Iwase M; Iino K; Oku M; Nohara S; Asano T; Doi Y; Iida M
    Diabetes Metab Res Rev; 2009 May; 25(4):344-50. PubMed ID: 19330879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the SGLT2 inhibitor ipragliflozin on food intake, appetite-regulating hormones, and arteriovenous differences in postprandial glucose levels in type 2 diabetic rats.
    Tahara A; Kondo Y; Takasu T; Tomiyama H
    Biomed Pharmacother; 2018 Sep; 105():1033-1041. PubMed ID: 30021338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus.
    Fineman M; Weyer C; Maggs DG; Strobel S; Kolterman OG
    Horm Metab Res; 2002 Sep; 34(9):504-8. PubMed ID: 12384827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
    Kolterman OG; Kim DD; Shen L; Ruggles JA; Nielsen LL; Fineman MS; Baron AD
    Am J Health Syst Pharm; 2005 Jan; 62(2):173-81. PubMed ID: 15700891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.